NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
TrumpMajorMilitaryStrikesFebruaryIranAnnouncesIranianNewsAdditionalDigestSundayTimelineYearNuclearTargetingGameHumanoidGlobalMarketNipahLimitedChineseCampaign
TrumpMajorMilitaryStrikesFebruaryIranAnnouncesIranianNewsAdditionalDigestSundayTimelineYearNuclearTargetingGameHumanoidGlobalMarketNipahLimitedChineseCampaign
All Articles
Adven Biotech says it India first homeopathic brand to get NABL certification
economictimes.indiatimes.com
Published 7 days ago

Adven Biotech says it India first homeopathic brand to get NABL certification

economictimes.indiatimes.com · Feb 15, 2026 · Collected from GDELT

Summary

Published: 20260215T144500Z

Full Article

SynopsisAdven Biotech achieves a significant milestone as India's first homeopathy brand to earn NABL certification. This accreditation underscores India's commitment to global healthcare standards in the Ayush sector. The certification validates Adven's quality control and testing laboratories, aligning with Prime Minister Modi's vision for Ayush. It aims to boost confidence and expand the global acceptance of Indian homeopathy.PTINew Delhi, Pharmaceutical firm Adven Biotech has claimed to become the country's first homeopathy brand to receive certification from the National Accreditation Board for Testing and Calibration Laboratories (NABL), reinforcing India's push for global-quality healthcare standards in the Ayush sector. The company said in a statement that the accreditation aligns with Prime Minister Narendra Modi's vision of positioning Ayush as a trusted global healthcare system, backed by science, quality, and international standards. According to Adven Biotech, the NABL certification sets a new benchmark for accuracy, transparency, and credibility in homeopathic medicine manufacturing -- an area where quality assurance has long been a concern, it said. The accreditation ensures that Adven's quality control and testing laboratories meet the most stringent national and international standards. It not only enhances confidence among doctors and patients but also opens doors for wider acceptance of Indian homeopathy in global markets, the company said. Speaking on the achievement, Adesh Sharma, CEO of Adven Biotech, said, "Prime Minister Narendra Modi's vision is very clear that Indian systems of medicine must stand on global platforms with proven quality and scientific validation. "The NABL certification is not just an honour for Adven, it is our responsibility towards millions of patients who trust homeopathy for safe and effective healing," he said. Founded with a mission to modernise homeopathy without compromising its core principles, Adven Biotech has consistently focused on research-driven formulations, ethical practices, and advanced manufacturing systems, according to the statement. The company had earlier received the 'Ayush premium mark', making it one of the very few homeopathy brands in India to hold both prestigious recognitions. The Ayush mark is a certification for quality Ayush products made in the country. Sharma added that with the NABL certification, every test, process, and medicine at Adven is now validated through globally accepted protocols. "This means better consistency, better outcomes, and greater trust for patients not just in metros, but in smaller cities and towns as well," he said.Health experts have noted that as India pushes to become a global Ayush hub, certifications such as NABL are crucial to counter scepticism and position Indian homeopathy as standardised, evidence-based, and export-ready. Read More News on...moreless


Share this story

Read Original at economictimes.indiatimes.com

Related Articles

economictimes.indiatimes.comabout 4 hours ago
pregnancy : One toxic exposure in pregnancy linked to disease risk across 20 generations , shocking rat study finds

Published: 20260222T170000Z

economictimes.indiatimes.comabout 7 hours ago
SBI aims to hike its green advances portfolio up to 10 pc by 2030

Published: 20260222T144500Z

economictimes.indiatimes.com1 day ago
Barcelona El Caganer to Bitcoin : A satire on money and modern myths

Published: 20260221T183000Z

economictimes.indiatimes.com1 day ago
General Catalyst on its $5 billion India bet and going beyond venture capital to company creation

Published: 20260221T101500Z

economictimes.indiatimes.com2 days ago
US and Iran slide towards conflict as military buildup eclipses talks

Published: 20260221T030000Z

economictimes.indiatimes.com2 days ago
Horoscope Today , 21st February , 2026 : Fresh Starts , Healing Energy & Renewed Confidence Ahead

Published: 20260220T170000Z